Although debate over the cut-off points will continue, this should not detract from the urgency of tackling the problem of obesity. Our data indicate that overweight and obesity on the basis of body mass index have increased noticeably since 1984. Most studies have shown poor prediction of adult obesity from child assessments but a consistent positive correlation between child and adult overweight and obesity.
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How women with a family history of breast cancer and their general practitioners act on genetic advice in general practice: prospective longitudinal study Geertruida H de Bock, Christi J van Asperen, Josephine M de Vries, George C H A Hageman, Machiel P Springer, Job Kievit
The most important risk factor for breast cancer, besides advanced age, is a family history of breast cancer. General practitioners play an important role in identifying women who are at increased risk of breast cancer, 1 especially women who are too young to be eligible for population screening. In a prospective longitudinal study with three years of follow up, we studied women's compliance with advice provided by their general practitioner that was based on assessment of genetic risk and whether this genetic advice was in line with the advice of a clinical geneticist.
Participants, methods, and results
The women were patients at a primary healthcare centre linked to a university in the Netherlands. The centre, whose six general practitioners serve 11 500 patients, uses only computerised medical records. This system allows records of patients with specific risk factors and diseases to be marked and selected. A total of 2000 of the 2220 patients aged between 25 and 50 consulted their general practitioner between April 1994 and July 1995, and of these 81 sought advice on their familial risk of breast cancer. 2 These women were subsequently interviewed twice. In summer 1995, 67 of the 81 women were interviewed about their family history of breast cancer. A clinical geneticist reviewed each family history, calculated a relative risk of breast cancer for each woman (from < 2, representing a normal or slightly increased risk, to >3, a highly increased risk) and gave genetic advice to the general practitioner (table). The genetic advice was in line with Dutch national guidelines as developed in 1999-2000. In autumn 1995 the general practitioners discussed this advice and the risk assessment with each woman in a single consultation (n = 63; four women had moved). In autumn 1998, 42 of the women were asked about their reasons for their compliance (or non-compliance) with the genetic advice and with advice on breast self examination. Data on the genetic advice given by the general practitioner to each patient, the surveillance given by the general practitioner (annual palpation by the general practitioner and annual mammography), and patients' visits to family cancer clinics were extracted from the medical records (n = 63). The medical ethics committee of the Leiden University Medical Centre approved the study protocol.
The clinical geneticist's advice was not followed by the general practitioner in 30% of the individual consultations; the general practitioners advised surveillance more frequently than did the geneticist (table) . Women appreciated surveillance more than reassurance or referral to a family cancer clinic. Nearly 25% of the women reported that they performed breast self examination at least monthly. One third of the women were compliant with the advice on surveillance. The main reasons given for non-compliance were not remembering to do preventive activities and a lack of confidence in the value of surveillance.
Comment
The value of giving genetic advice on breast cancer in primary care is questionable, for three reasons. Firstly, women showed a low level of compliance with genetic advice as given by general practitioners. This is in line with results from other studies on the effectiveness of annual mammography in general practice for asymptomatic women with a family history of breast cancer. 3 Secondly, there was a low level of compliance among general practitioners with the clinical geneticist's advice. Thirdly, there is no evidence that surveillance is effective in women under 50. 4 5 Breast self examination in women under 50 has not been shown to reduce mortality, not even when combined with palpation by a general practitioner, 4 and the sensitivity of mammography in women without breast symptoms is lower when the women are under 50. 5 Nevertheless, we believe that there is a place for genetic advice in general practice and that further research could improve its effectiveness.
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Raising concerns about family history of breast cancer in primary care consultations: prospective, population based study
Women's Concerns Study Group
Following the availability of genetic tests for the genes for breast cancer BRCA1 and 2, genetic centres have reported increasing referral, often of women who are at low risk of breast cancer but who are concerned about their chances of inheriting it, and they have called for better management in primary care. 1 To inform appropriate management strategies we counted consultations in primary care in which a family history of breast cancer was mentioned. We obtained ethical approval from the Cambridge local research ethics committee.
Population, method, and results
Nineteen of the 36 partnerships with four or more partners in one health authority were recruited by letter and visit (mean list size 8904 (SD 2231); 74% training practices). A total of 240 clinicians participated: 152 doctors and 88 nurses, including locums and those working part time.
Each practice collected data over four weeks between August 1997 and July 1998. After all consultations with women aged 16 or older, clinicians recorded the patient's reference number, birth date, mention of a family history of breast cancer or other cancers, breast symptoms, risk of breast cancer, and who first mentioned any of these topics. Consultation data were checked against records of attendance at the practice. Agreement between the patient and clinician on who first mentioned a family history of breast cancer was assessed in a selected subsample of women. These women were invited to participate in a telephone interview by letter (no reminders). Respondents included 39 of 107 women classified as originating discussion of a family history of breast cancer and 33 of a 10% sample of those classified as not originating such discussions (total 681). Data were double-entered and analysed using STATA 5.0 (Statacorp, College Station, TX).
Eighteen of 19 practices participated, and 20 614 of 24 269 consultations (85%) were usable. A sensitivity analysis that assumed that all missing consultations came from the practice with the highest or lowest rate of reporting for a family history of breast cancer gave results within the confidence intervals of the main analysis. No differences in frequency of mentions of family history of breast cancer by clinicians were found over time.
Of the topics recorded, breast symptoms were mentioned in consultation most often, and family his- 
